Wenchao Zhang

Dr. Wenchao Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 March 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
LQLin Qi
Lin Qi
FCFangyue Chen
Fangyue Chen
LWLu Wang
Lu Wang
ZYZhimin Yang
Zhimin Yang
WZWenchao Zhang
Wenchao Zhang
ZLZhihong Li
Zhihong Li
Background: Soft-tissue sarcoma (STS) is a massive threat to human health due to its high morbidity and malignancy. STS also represents more than 100 histologic and molecular subtypes, with different prognosis. There is growing evidence that anoikis play a key role in the proliferation and invasion of tumors. However, the effects of anoikis in the immune landscape and the prognosis of STS remain unclear.Methods: We analyzed the genomic and transcriptomic profiling of 34 anoikis-related genes (ARGs) in patient cohort of pan-cancer and STS from The Cancer Genome Atlas (TCGA) database. Single-cell transcriptome was used to disclose the expression patterns of ARGs in specific cell types. Gene expression was further validated by real-time PCR and our own sequencing data. We established the Anoikis cluster and Anoikis subtypes by using unsupervised consensus clustering analysis. An anoikis scoring system was further built based on the differentially expressed genes (DEGs) between Anoikis clusters. The clinical and biological characteristics of different groups were evaluated.Results: The expressions of most ARGs were significantly different between STS and normal tissues. We found some common ARGs profiles across the pan-cancers. Network of 34 ARGs demonstrated the regulatory pattern and the association with immune cell infiltration. Patients from different Anoikis clusters or Anoikis subtypes displayed distinct clinical and biological characteristics. The scoring system was efficient in prediction of prognosis and immune cell infiltration. In addition, the scoring system could be used to predict immunotherapy response.Conclusion: Overall, our study thoroughly depicted the anoikis-related molecular and biological profiling and interactions of ARGs in STS. The Anoikis score model could guide the individualized management.

18 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
RXRuiling Xu
Ruiling Xu
Lin QiLin Qi
Lin Qi
XRXiaolei Ren
Xiaolei Ren
WZWenchao Zhang
Wenchao Zhang
CLChenbei Li
Chenbei Li
ZLZhihong Li
Zhihong Li
Soft tissue sarcoma (STS) is one of the rarest but most aggressive cancer. It is important to note that intratumoral hypoxia and tumor microenvironment (TME) infiltration play a significant role in the growth and therapeutic resistance of STS. The goal of this study was therefore to determine whether linking hypoxia-related parameters to TME cells could provide a more accurate prediction of prognosis and therapeutic response. An analysis of 109 hypoxia-related genes and 64 TME cells was conducted in STS. Hypoxia-TME classifier was constructed based on 6 hypoxia prognostic genes and 8 TME cells. As a result, we evaluated the prognosis, tumor, and immune characteristics, as well as the effectiveness of therapies in Hypoxia-TME-defined subgroups. The Lowplus group showed a better prognosis and therapeutic response than any other subgroup. It is possible to unravel these differences based on immune-related molecules and somatic mutations in tumors. Further validation of Hypoxia-TME was done in an additional cohort of 225 STS patients. Additionally, we identified five key genes through differential analysis and RT-qPCR, namely, ACSM5, WNT7B, CA9, MMP13, and RAC3, which could be targeted for therapy. As a whole, the Hypoxia-TME classifier demonstrated a pretreatment predictive value for prognosis and therapeutic outcome, providing new approaches to therapy strategizing for patients.

16 September 2022 in Medicine
Verified
Journal Article
Open access
CWCong Wei
Cong Wei
WXWen-qing Xie
Wen-qing Xie
WZWenchao Zhang
Wenchao Zhang
NTning tang
ning tang
YSYang Su
Yang Su
THTianlong Huang
Tianlong Huang
Background: To analyze global trends in focus and funding of research related to high tibial osteotomy (HTO) and to identify the 100 most cited articles in this field. Methods: A Web of Science search was used to identify HTO publications in English-language scientific journals from January 1967 till February 3th, 2021. Results were filtered to the 100 most cited articles by reading the abstract or full-text paper. Information of these articles was recorded for further analysis. The 10 top-cited articles during the last 5 years and the 10 top-cited articles about HTO ranked by average citations per year were selected to predict research trends. Results: In all, 48 out of the 100 top-cited articles were published between 2000 and 2010. The United States of America was the primary contributor (n = 29) followed by Germany (n = 17) and Japan (n = 11). The total number of citations per article ranged from 65 to 563, median 108, mean 135 (standard deviation = 84). The American Journal of Bone and Joint Surgery accounted for 23 out of the 100 top-cited articles. Koshino T was the most cited author (603 citations). The most frequently highlighted study theme was prognostic research. Patient-based clinical research was the dominant study design (85%). The majority of articles (48 out of 100) were level IV evidence with a mean of 141 (standard deviation = 97) citations. Top-cited articles in the last 5 years focused on open wedge osteotomy. Conclusion: Technical optimization of open wedge osteotomy has emerged as the main area of research in HTO. More specifically, recent publications focus on the surgical technology, cartilage repair and new fixation devices. Besides, papers with a high level of evidence are needed for the development of HTO.

23 February 2021 in Research Square
Verified
Preprint
Open access
PDF file
Lin QiLin Qi
Lin Qi
WZWenchao Zhang
Wenchao Zhang
XRXiaolei Ren
Xiaolei Ren
CLChaoqian Liu
Chaoqian Liu
Chao TuChao Tu
Chao Tu
ZLZhihong Li
Zhihong Li
Background: Clinical characteristics and sociodemographic of differentiated thyroid carcinoma (DTC) patients with bone metastasis (BM) remain unclear. Methods: Data of patients with newly diagnosed DTC from 2010 to 2016 were retrieved from Surveillance, Epidemiology, and End Results (SEER) database. Incidence trend of BM in patients with DTC was explored by joinpoint regression. Multivariable logistic regression was utilized to figure out predictors of BM at initial presentation of DTC, and was further evaluated by receiver operator characteristics (ROC) analysis. Multivariable Cox regression was applied to reason out factors associated with overall survival and DTC-specific survival.Results: A total of 67,176 patients with DTC were identified from the database, with 0.36% (244/67176) presenting BM at the time of diagnosis. The age-adjusted incidence of BM in DTC was relatively stable during study period with an average annual percentage change (AAPC) of 2.52. Multivariable logistic regression recognized eight factors as predictors of presence of BM among the entire cohort. Multivariable Cox regression indicated multiple metastatic sites, total thyroidectomy and radioisotopes as predictors for survival of patients.Conclusions: The incidence of BM in DTC patients has been stable in recent years. Predictors and prognostic factors of BM in DTC patients were identified in this study.